Blood Collection From Individuals With Lung Disease for Genetic Studies

Overview

This is a research study where researchers are collecting blood to evaluate the genetic characteristics of individuals with chronic lung diseases, including asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease, cystic fibrosis, and lung cancer.

Full Title of Study: “Collection of Blood for Gene Expression/Genomic Studies in Individuals With Chronic Lung Disease”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: August 2015

Detailed Description

The investigators hope to be able to identify an association between a genetic make-up in the blood samples and the risks of developing a particular lung disease, or severity of a lung disease. The findings of this study might be important to develop future preventative methods and potential treatments for the management of lung disease. The investigators aim to collect blood samples from 300 people with lung disease and 300 controls over 5 years.

Arms, Groups and Cohorts

  • 1: Lung Disease
    • Individuals with at least one of the following: (1)symptoms consistent with pulmonary disease; (2) chest X-ray consistent with lung disease; (3) pulmonary function tests consistent with lung disease; (4) lung biopsy consistent with lung disease; (5) family history of lung disease; (6) patients with diseases of organs with known association with lung disease; (7) individuals suspected of history of lung diseased based on history and/or physical examination
  • 2: Normal Controls
    • Individuals without a history of lung disease

Clinical Trial Outcome Measures

Primary Measures

  • Establish a set of normal ranges for various parameters in healthy individual specimens and compare to specimens from individuals with lung disease to determine parameters resulting in disease susceptibility and severity.
    • Time Frame: 5 years

Participating in This Clinical Trial

Inclusion Criteria

  • Must provide informed consent – Males and females, age 18 years and older – Lung disease proven by at least one of the following: – symptoms consistent with pulmonary disease – chest X-rays consistent with lung disease – pulmonary function tests consistent with lung disease – lung biopsy consistent with lung disease – family history of lung disease – disease of organs with know associated with lung disease – individuals suspected of history of lung disease based on history and/or physical examination – normal controls (individuals without history of lung disease) to be sampled to provide a comparison to the lung disease cohort. Exclusion Criteria:

  • Drug and/or alcohol abuse within the past six months – Females who are pregnant or nursing

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Weill Medical College of Cornell University
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Ronald G Crystal, MD, Principal Investigator, The New York Presbyterian Hospital — Weill Medical College of Cornell University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.